» Authors » Srinivas V Koduru

Srinivas V Koduru

Explore the profile of Srinivas V Koduru including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 590
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Celik N, Koduru S, Ravnic D, Ozbolat I, Hayes D
Tissue Eng Part A . 2024 Jun; 30(17-18):536-549. PMID: 38874518
Cell aggregates are widely used to study heterotypic cellular interactions during the development of vascularization . In this study, we examined heterotypic cellular spheroids made of adipose-derived stem cells and...
2.
Modlin I, Kidd M, Drozdov I, Boegemann M, Bodei L, Kunikowska J, et al.
Prostate . 2024 Apr; 84(9):850-865. PMID: 38571290
Introduction: We describe the development of a molecular assay from publicly available tumor tissue mRNA databases using machine learning and present preliminary evidence of functionality as a diagnostic and monitoring...
3.
Horchler S, Hancock P, Sun M, Liu A, Massand S, El-Mallah J, et al.
Microcirculation . 2023 Nov; 31(1):e12835. PMID: 37947797
Objective: The success of engineered tissues continues to be limited by time to vascularization and perfusion. Recently, we described a simple microsurgical approach, termed micropuncture (MP), which could be used...
4.
Ataie Z, Horchler S, Jaberi A, Koduru S, El-Mallah J, Sun M, et al.
Small . 2023 Oct; 20(8):e2307928. PMID: 37824280
Bulk hydrogel scaffolds are common in reconstructive surgery. They allow for the staged repair of soft tissue loss by providing a base for revascularization. Unfortunately, they are limited by both...
5.
Suresh D, Srinivas A, Prashant A, Satish S, Vishwanath P, Nataraj S, et al.
Front Oncol . 2023 Jun; 13:1130380. PMID: 37361585
Background And Aims: Angiogenesis is a key factor in the growth and metastasis of hepatic tumors and thus a potential therapeutic target in hepatocellular carcinoma (HCC). In this study, we...
6.
McLaughlin C, Datta P, Singh Y, Lo A, Horchler S, Elcheva I, et al.
Cells . 2022 Nov; 11(21). PMID: 36359762
Extracellular vesicles (EVs) are small lipid bilayer-delimited particles that are naturally released from cells into body fluids, and therefore can travel and convey regulatory functions in the distal parts of...
7.
Goldenberg D, McLaughlin C, Koduru S, Ravnic D
Front Surg . 2021 Nov; 8:731031. PMID: 34805257
Many pathologies, congenital defects, and traumatic injuries are untreatable by conventional pharmacologic or surgical interventions. Regenerative engineering represents an ever-growing interdisciplinary field aimed at creating biological replacements for injured tissues...
8.
Koduru S, Leberfinger A, Ozbolat I, Ravnic D
Stem Cells Dev . 2021 Sep; 30(23):1153-1170. PMID: 34514867
Diabetes is a pandemic manifested through glucose dysregulation mediated by inadequate insulin secretion by beta cells. A beta cell replacement strategy would transform the treatment paradigm from pharmacologic glucose modulation...
9.
Forghani A, Koduru S, Chen C, Leberfinger A, Ravnic D, Hayes D
Regen Eng Transl Med . 2020 Dec; 6(1):101-110. PMID: 33344757
In this study, CD34/CD31 progenitor cells were isolated from the stromal vascular fraction (SVF) of adipose tissue using magnetic activated cell sorting. The endothelial differentiation capability of these cells was...
10.
Hancock P, Koduru S, Sun M, Ravnic D
Microvasc Res . 2020 Dec; 134:104121. PMID: 33309646
The success of engineered tissues continues to be limited by time to vascularization and perfusion. Here, we studied the effects of precision injury to a recipient macrovasculature in promoting neovessel...